North Carolina's pharmaceutical sector is notable for its array of innovative companies focused on drug development and biosciences. The state hosts organizations specializing in rare diseases, gene therapies, and biopharmaceutical contract services. With a scientific community that is thriving, collaboration between academia and industry fosters advancements in treatment options. North Carolina's favorable regulatory environment and skilled labor force attract both startups and established firms, making the state a rising hub at the intersection of healthcare and technology.

The companies featured here range from small startups to larger corporate entities, operating out of key locations like Durham and Cary. Founded between 1904 and 2022, they include specialists in women’s health, injectable treatments, and contract manufacturing. Firms like Mycovia Pharmaceuticals and FUJIFILM Diosynth Biotechnologies illustrate North Carolina's dedication to addressing unmet medical needs through innovative technology and research.

Continue reading to explore the top pharmaceuticals companies in North Carolina.

Top 25 Pharmaceuticals Companies Companies in North Carolina

1. Mycovia Pharmaceuticals

• Website: mycovia.com
• Ownership type: Private
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: mycovia-pharmaceuticals

Mycovia Pharmaceuticals is a biopharmaceutical company based in Durham, North Carolina, established in 2018. The company is dedicated to developing innovative therapies for patients with medical conditions that are often overlooked, with a strong emphasis on women's health. Mycovia's mission is to address unmet medical needs through the research and commercialization of novel pharmaceuticals. Their primary product, VIVJOA® (oteseconazole), is designed to treat conditions that have historically lacked effective treatment options. Mycovia is committed to ensuring that all patients receive equal treatment and support, reflecting their core values of respect, integrity, and innovation. The company is actively engaged in clinical development, with a pipeline that includes therapies for various fungal infections and other conditions. Mycovia's leadership team brings extensive experience from the pharmaceutical industry, further enhancing their capability to deliver impactful solutions to patients.

2. Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.

• Website: bambootherapeutics.com
• Ownership type: Corporate
• Headquarters: Chapel Hill, North Carolina, United States (USA)
• Latest funding: $654.0M, August 2016
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: bamboo-therapeutics

Bamboo Therapeutics, Inc., a wholly owned subsidiary of Pfizer Inc., is based in Chapel Hill, North Carolina. Founded in 2014, the company is dedicated to the development of innovative therapies, particularly focusing on gene therapy for rare diseases. This specialization is crucial as it addresses unmet medical needs in smaller patient populations, which often receive less attention from larger pharmaceutical firms. Bamboo Therapeutics leverages Pfizer's extensive resources and expertise in research and development, enhancing its ability to bring new treatments to market. The company has attracted significant funding, amounting to $654 million, which underscores its potential and the confidence investors have in its mission to transform the treatment landscape for rare diseases.

3. Chiesi USA, Inc.

• Website: chiesiusa.com
• Ownership type: Family Owned
• Headquarters: Cary, North Carolina, United States (USA)
• Employee distribution: United States (USA) 98%, Other 2%
• Latest funding: Other (Grant), $3,000, August 2020
• Founded year: 1935
• Headcount: 201-500
• LinkedIn: chiesi-usa

Chiesi USA, Inc., headquartered in Cary, North Carolina, is a family-owned pharmaceutical company that specializes in developing and commercializing medical products for hospital care and rare diseases. Founded in 1935, the company has evolved significantly, particularly after its establishment in the U.S. market in 2014 through the acquisition of Cornerstone Therapeutics. Chiesi USA focuses on addressing unmet medical needs, providing innovative solutions that enhance patient care. The company’s product portfolio includes treatments for various conditions, emphasizing respiratory and rare diseases. With a workforce of approximately 491 employees, Chiesi USA has quickly become a top-producing affiliate within the Chiesi Group, which operates globally. The company is also committed to sustainability and community engagement, pledging 1% of its annual revenues to social initiatives. This commitment reflects its broader mission to create a positive impact in healthcare and society.

4. BE Pharmaceuticals, Inc.

• Website: be-pharmaceuticals.com
• Ownership type: Private
• Headquarters: Cary, North Carolina, United States (USA)
• Employee distribution: India 90%, United States (USA) 10%
• Founded year: 2019
• Headcount: 1-10
• LinkedIn: be-pharmaceuticals-inc

BE Pharmaceuticals, Inc., based in Cary, North Carolina, is a pharmaceutical manufacturer that specializes in injectable products and vaccines. Established in 2019, the company has quickly positioned itself as a reliable supplier of essential medications to healthcare facilities, including hospitals and pharmacies. With a strong emphasis on quality, BE Pharmaceuticals operates from a USFDA-approved facility, ensuring that their products meet stringent regulatory standards. The company is part of Biological E. Limited, which has a rich history in vaccine development and manufacturing. This connection allows BE Pharmaceuticals to leverage extensive expertise in sterile manufacturing and a robust pipeline of products. Currently, they have over 20 products in various stages of development and aim to introduce 5-7 new products each year. Their commitment to providing reliable quality medicine and lowering costs reflects their dedication to improving patient access to essential treatments.

5. FUJIFILM Diosynth Biotechnologies

• Website: fujifilmdiosynth.com
• Ownership type: Corporate
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: Denmark 43%, United States (USA) 40%, United Kingdom (UK) 17%
• Latest funding: $890.0M, August 2019
• Founded year: 2011
• Headcount: 1001-5000
• LinkedIn: fujifilm-diosynth-biotechnologies

FUJIFILM Diosynth Biotechnologies, founded in 2011, operates out of Morrisville, North Carolina, and has a workforce of over 5,000 employees. The company specializes in contract development and manufacturing services, focusing on biologics, vaccines, and advanced therapies. They partner with pharmaceutical and biotechnology firms, providing expertise in cGMP processes to ensure the safe and effective delivery of products. Their global presence includes facilities in the United States, Denmark, the United Kingdom, and Japan, allowing them to support clients through all phases of drug development, from pre-clinical studies to commercialization. The company has made significant investments, including a recent funding amount of $890 million, which underscores their commitment to expanding their capabilities and enhancing their service offerings in the biopharmaceutical sector.

6. Kowa Research Institute, Inc.

• Website: kowaus.com
• Ownership type: Corporate
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: United States (USA) 96%, Vietnam 4%
• Latest funding: August 2008
• Founded year: 1997
• Headcount: 11-50
• LinkedIn: kowa-research-institute-inc.

Kowa Research Institute, Inc., based in Morrisville, North Carolina, is a pharmaceutical company dedicated to the clinical development of new drugs. Established in 1997, the company operates as a division of Kowa Co., Ltd., which is headquartered in Nagoya, Japan. Kowa Research Institute specializes in innovative solutions targeting lifestyle-related diseases, immunity, and inflammation. The company collaborates with various healthcare organizations and research institutions to advance drug development through rigorous clinical trials and research initiatives. Kowa Research Institute also oversees the U.S. development of Kowa's new drug candidates, with a strategic focus on areas such as cardiovascular and metabolic diseases. Their commitment to research and development is evident in their partnerships and the establishment of Kowa Pharma Development in Boston, which serves as the global clinical development headquarters for Kowa Co., Ltd. This strategic positioning allows Kowa Research Institute to play a significant role in the pharmaceutical landscape, contributing to advancements in treatment options for various health conditions.

7. Ribometrix Inc.

• Website: ribometrix.com
• Ownership type: Venture Capital
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $7.8M, September 2019
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: ribometrix

Ribometrix Inc., founded in 2014 and based in Durham, North Carolina, is a biotechnology firm that specializes in drug discovery and development with a focus on RNA biology. The company is dedicated to creating small molecule therapeutics aimed at treating complex diseases, including various forms of cancer, central nervous system disorders, and autoimmune diseases. Ribometrix employs a unique platform that allows them to target RNA directly, preventing the production of disease-causing proteins. This innovative approach positions them at the forefront of a new paradigm in drug discovery. Ribometrix has received significant venture capital funding, totaling $7.8 million as of September 2019, which supports their research and development efforts. Their pipeline includes programs targeting cell proliferation disorders and other serious health conditions, showcasing their commitment to advancing therapeutic options in the pharmaceutical sector.

8. Inhalon Biopharma

• Website: inhalon.com
• Ownership type: Venture Capital
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $2.0M, November 2022
• Founded year: 2018
• Headcount: 1-10
• LinkedIn: inhalon-biopharma

Inhalon Biopharma is a biotechnology company based in Durham, North Carolina, founded in 2018. The company specializes in developing inhaled antibody treatments aimed at acute respiratory infections, including respiratory syncytial virus (RSV), influenza, and SARS-CoV-2. Their unique platform utilizes a 'test-to-treat' model, allowing for self-administration of treatments at home, which could significantly enhance patient comfort and accessibility. Inhalon has received various funding, including a $7 million grant from the U.S. Army Medical Research and Development Command to support their COVID-19 treatment efforts. Their research is backed by a robust pipeline and promising early clinical results, positioning them as a noteworthy player in the biotechnology sector.

9. AreteiaTx

• Website: areteiatx.com
• Ownership type: Venture Capital
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $75.0M, February 2024
• Founded year: 2022
• Headcount: 11-50
• LinkedIn: areteiatx

Areteia Therapeutics, based in Durham, North Carolina, is a biotechnology company founded in 2022. The firm is dedicated to developing dexpramipexole, an oral treatment specifically targeting eosinophilic asthma, a severe form of asthma that affects millions globally. AreteiaTx is currently conducting Phase 3 clinical trials to validate the safety and efficacy of dexpramipexole, which has shown promise in previous studies involving over 1,500 patients. The company has recently secured $75 million in Series A funding, which underscores investor confidence in their approach to providing effective alternatives to existing therapies for asthma patients. With a team of experienced drug developers, AreteiaTx is focused on transforming the patient experience in managing eosinophilic asthma, aiming to bring the first oral treatment to market for this condition.

10. Accord Healthcare US

• Website: accordhealthcare.us
• Ownership type: Private
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2002
• Headcount: 201-500
• LinkedIn: accord-healthcare-us

Accord Healthcare US, a subsidiary of Intas Pharmaceuticals, is based in Durham, North Carolina. Founded in 2002, the company specializes in generic medications, aiming to provide high-quality and affordable pharmaceutical products to healthcare providers and patients. Accord Healthcare is committed to innovation and safety, ensuring access to essential medications. The company has a strong focus on research and development, with a pipeline that includes a variety of dosage forms such as orals, topicals, and injectables. Notably, Accord Healthcare holds a significant market share in oncology, particularly in chemotherapy injectables. Their manufacturing capabilities are supported by FDA-approved facilities in India, which have a solid regulatory track record. This combination of product development, manufacturing excellence, and a commitment to improving patient access underscores Accord Healthcare's role in the pharmaceutical industry.

11. Veloxis Pharmaceuticals, Inc.

• Website: veloxis.com
• Ownership type: Corporate
• Headquarters: Cary, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.3B, November 2019
• Founded year: 2002
• Headcount: 51-200
• LinkedIn: veloxis-pharmaceuticals

Veloxis Pharmaceuticals, Inc., based in Cary, North Carolina, is a pharmaceutical company founded in 2002. The company is dedicated to developing innovative therapies specifically for transplant medicine. Their primary product, ENVARSUS XR, is an extended-release formulation of tacrolimus designed to prevent organ rejection in kidney transplant patients. This medication is crucial for patients who have undergone kidney transplants, as it helps manage the risk of rejection when used alongside other immunosuppressants. Veloxis is also engaged in clinical trials for additional therapies, such as VEL-101, aimed at further enhancing transplant outcomes. As part of the Asahi Kasei group, Veloxis benefits from a global network that supports its growth and innovation in the field of transplant medicine. The company is committed to improving patient experiences and outcomes through its products and ongoing research efforts.

12. Bright Path Laboratories

• Website: brightpathlabs.com
• Ownership type: Private
• Headquarters: Kannapolis, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), $8.5M, November 2021
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: brightpathlabs

Bright Path Laboratories, founded in 2019 and based in Kannapolis, North Carolina, is a private pharmaceutical manufacturer dedicated to transforming the way medicines are sourced and produced in the United States. The company specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) and drug formulations, with a strong emphasis on sustainability and affordability. Bright Path employs advanced manufacturing technologies, including their patented Spinning-Tube-in-Tube (STT) Reactor™, which allows for efficient production processes that minimize waste and reduce costs. They are particularly focused on addressing the healthcare crisis in America by ensuring a secure supply chain for essential medicines. The company has also received funding, amounting to $8,462,500 in November 2021, which supports their mission to provide safe and effective medicines, including those for rare and orphan diseases. Bright Path Laboratories is committed to working closely with patient communities, researchers, and healthcare professionals to improve access to quality medicines.

13. Ironshore Pharmaceuticals Inc.

• Website: ironshorepharma.com
• Ownership type: Corporate
• Headquarters: Durham, North Carolina, United States (USA)
• Latest funding: $525.0M, July 2024
• Founded year: 2008
• Headcount: 201-500
• LinkedIn: ironshore-pharmaceuticals-inc

Ironshore Pharmaceuticals Inc. is a pharmaceutical company based in Durham, North Carolina, established in 2008. The company specializes in developing innovative treatment options, particularly for Attention Deficit Hyperactivity Disorder (ADHD). Ironshore employs proprietary drug delivery systems designed to improve the effectiveness of medications for patients and caregivers. Their focus on research and development aims to address unmet medical needs within the pharmaceutical sector. Recently, Ironshore secured $525 million in funding, reflecting strong investor confidence in its potential. However, it is noteworthy that Ironshore has been acquired by Collegium Pharmaceutical, Inc., which may influence its operational independence and strategic direction moving forward.

14. Parexel

• Website: parexel.com
• Ownership type: Private Equity
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: India 34%, United States (USA) 17%, Romania 5%, Other 44%
• Latest funding: $8.5B, July 2021
• Founded year: 1983
• Headcount: 10001+
• LinkedIn: parexel

Parexel International, founded in 1983 and based in Durham, North Carolina, is a prominent clinical research organization (CRO) specializing in biopharmaceutical services. With a workforce exceeding 20,000 employees, Parexel provides a comprehensive range of services that span the entire clinical development process. This includes early-stage trials, regulatory consulting, and market access strategies. The company assists biopharmaceutical firms in expediting the drug approval process while ensuring compliance with regulatory standards. Parexel's expertise covers various therapeutic areas, such as oncology, neuroscience, and rare diseases, making them a valuable partner for companies looking to navigate the complexities of clinical trials. Their recent funding of $8.5 billion in July 2021 underscores their financial backing and capacity to innovate within the industry. Overall, Parexel's extensive experience and operational capabilities position them as a significant entity in the pharmaceutical landscape.

15. CMP Pharma, Inc.

• Website: cmppharma.com
• Ownership type: Private Equity
• Headquarters: Farmville, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2012
• Founded year: 1975
• Headcount: 11-50
• LinkedIn: cmp-pharma-inc.

CMP Pharma, Inc., founded in 1975 and based in Farmville, North Carolina, is a specialty pharmaceutical company dedicated to the development and manufacturing of oral liquid and semi-solid topical products. The company primarily serves niche markets, focusing on patients who have difficulty swallowing traditional medications. CMP Pharma has made significant strides in the industry by introducing several FDA-approved products, including the first oral liquid suspension of atorvastatin and tadalafil. Their portfolio also includes generic and non-prescription products, which are distributed to hospitals, long-term care facilities, and retail channels. CMP Pharma's commitment to addressing unmet medical needs, particularly for vulnerable patient populations, underscores their role in the pharmaceutical sector. They have maintained a consistent presence in the market since their inception, emphasizing innovation and compliance with regulatory standards.

16. N/a

• Website: greerlabs.com
• Ownership type: Private
• Headquarters: Lenoir, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1904
• Headcount: 51-200
• LinkedIn: greer-laboratories

Stallergenes Greer, based in Lenoir, North Carolina, has been a key player in the allergy immunotherapy sector since its founding in 1904. The company provides a comprehensive range of products and services aimed at healthcare professionals, including allergy testing extracts and skin-testing devices. Their GREER® Pharmacy offers tailored immunotherapy formulations, ensuring that healthcare providers have access to effective treatment options for their patients. Stallergenes Greer also engages in veterinary allergy solutions, showcasing their commitment to addressing allergy issues across species. With a dedicated focus on allergy management, they support healthcare providers through education and resources, enhancing the overall treatment experience for patients suffering from allergies.

17. Sprout Pharmaceuticals, Inc.

• Website: sproutpharma.com
• Ownership type: Corporate
• Headquarters: Raleigh, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.0B, August 2015
• Founded year: 2011
• Headcount: 11-50
• LinkedIn: sprout-pharmaceuticals-inc-

Sprout Pharmaceuticals, Inc., founded in 2011 and based in Raleigh, North Carolina, is a pharmaceutical company dedicated to advancing women's health. The company specializes in developing innovative solutions for sexual health, with a particular focus on addressing low libido in women. Their flagship product, Addyi, is the first and only FDA-approved medication for this condition, which has sparked significant conversation and awareness around women's sexual health issues. Sprout is committed to research and development, actively engaging in studies to enhance understanding of their products and improve patient outcomes. The company has also received substantial funding, totaling $1 billion, which underscores investor confidence in their mission and potential for growth. Sprout's culture promotes a unique approach to business, emphasizing boldness and creativity in their strategies to connect with patients and healthcare providers alike.

18. MedPharm

• Website: medpharm.com
• Ownership type: Corporate
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United Kingdom (UK) 49%, United States (USA) 48%, Other 3%
• Latest funding: July 2024
• Founded year: 1994
• Headcount: 51-200
• LinkedIn: medpharm

MedPharm, founded in 1994 and based in Durham, North Carolina, operates as a contract development and manufacturing organization (CDMO) within the pharmaceutical industry. The company specializes in the formulation development and production of topical and transdermal drug products. MedPharm offers a comprehensive suite of services, including in vitro testing, analytical methods, and late-stage development, catering primarily to pharmaceutical companies seeking expertise in drug formulation and regulatory compliance. With a workforce of approximately 264 employees, MedPharm has established a strong presence in both the United States and the United Kingdom. The recent merger with Tergus Pharma has further expanded their capabilities, allowing them to provide end-to-end solutions from early-stage development to full commercial production. MedPharm has a proven track record, having supported over 55 market-approved products globally, showcasing their commitment to quality and innovation in drug development.

19. Qualicaps

• Website: qualicaps.com
• Ownership type: Corporate
• Headquarters: Whitsett, North Carolina, United States (USA)
• Employee distribution: Spain 34%, Romania 32%, United States (USA) 22%, Other 12%
• Latest funding: March 2013
• Founded year: 1992
• Headcount: 1001-5000
• LinkedIn: qualicaps

Qualicaps, founded in 1992 and based in Whitsett, North Carolina, is a corporate entity that specializes in the manufacture of high-quality capsules and pharmaceutical processing equipment. The company caters to pharmaceutical manufacturers and health-related businesses, providing essential products that adhere to stringent industry standards. With a workforce distributed across several countries, including Spain, Romania, and Brazil, Qualicaps emphasizes innovation and quality in its operations. Their product portfolio includes both gelatin and plant-based capsules, designed for various pharmaceutical applications, including solid oral dosage forms and dry powder inhalers. Additionally, Qualicaps offers a range of equipment tailored to meet the needs of the pharmaceutical and nutritional markets, ensuring reliability and efficiency in production. Their commitment to scientific expertise and technical support further solidifies their role as a partner in the pharmaceutical industry.

20. Exela Pharma Sciences LLC

• Website: exelapharma.com
• Ownership type: Private
• Headquarters: Lenoir, North Carolina, United States (USA)
• Employee distribution: United States (USA) 98%, India 2%
• Latest funding: September 2021
• Founded year: 2005
• Headcount: 501-1000
• LinkedIn: exela-pharma-sciences-llc

Exela Pharma Sciences LLC, founded in 2005 and based in Lenoir, North Carolina, is a pharmaceutical manufacturer that specializes in sterile injectable products. The company operates as a contract development and manufacturing organization (CDMO), providing a range of services that include research and development, quality assurance, and logistics support. Exela's primary focus is on addressing drug shortages and enhancing patient care, particularly in the neonatal and pediatric populations. With a workforce of approximately 354 employees, the company has built a reputation for its commitment to quality, as reflected in its successful FDA inspection history. Exela's facilities are equipped to produce over one hundred million sterilized units annually, showcasing their capacity to meet significant market needs. Their strategic investments in manufacturing infrastructure and a strong emphasis on regulatory compliance further solidify their role in the pharmaceutical industry.

21. Immorna

• Website: immorna.com
• Ownership type: Private Equity
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: United States (USA) 83%, China 17%
• Latest funding: Other (Grant), August 2024
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: immorna

Immorna is a biotechnology firm based in Morrisville, North Carolina, founded in 2019. The company focuses on RNA-based therapeutics and vaccines, utilizing multiple RNA platforms, including self-replicating and circular RNA. Immorna provides contract development and manufacturing services, catering to pharmaceutical and research organizations. It has built a robust platform for RNA synthesis, purification, and analytical testing, which supports both clinical and commercial development. Immorna's pipeline includes candidates for cancer immunotherapy, infectious diseases, and rare genetic disorders. The company has received FDA IND clearance for its drug candidates, indicating its active involvement in clinical trials. With a growing intellectual property portfolio, Immorna is positioned to contribute significantly to the biotechnology and pharmaceutical sectors.

22. Marius Pharmaceuticals

• Website: mariuspharma.com
• Ownership type: Venture Capital
• Headquarters: Raleigh, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $6.0M, October 2021
• Founded year: 2017
• Headcount: 11-50
• LinkedIn: marius-pharmaceuticals

Marius Pharmaceuticals, based in Raleigh, North Carolina, is a pharmaceutical company that focuses on developing innovative therapies for testosterone deficiency, also known as hypogonadism. Founded in 2017, Marius has made significant strides in the industry with its flagship product, KYZATREX, an oral testosterone replacement therapy designed to treat adult men with low or absent testosterone levels due to specific medical conditions. The company aims to improve patient health and well-being through its specialized therapies, which are backed by research and clinical trials. Marius has received funding, amounting to approximately $6 million, which underscores investor interest in its mission and potential. The company is dedicated to addressing the growing health crisis related to testosterone deficiency, which affects a substantial portion of the male population, particularly those over 45 years of age. Marius Pharmaceuticals is committed to advancing the understanding and treatment of testosterone-related health issues, making it a notable entity in the pharmaceutical landscape.

23. Biologics, Inc.

• Website: biologicsinc.com
• Ownership type: Corporate
• Headquarters: Cary, North Carolina, United States (USA)
• Employee distribution: United States (USA) 97%, Somalia 3%
• Latest funding: $1.2B, February 2016
• Founded year: 1994
• Headcount: 201-500
• LinkedIn: biologics-inc-_151784

Biologics, Inc., operating under the name Biologics by McKesson, is a specialty pharmacy based in Cary, North Carolina. Founded in 1994, the company has built a reputation for providing personalized care and support for patients dealing with complex diseases, particularly in oncology and rare diseases. They offer a range of services designed to simplify access to therapies, including financial assistance coordination, patient adherence support, and rapid prescription delivery. Biologics collaborates with patients, healthcare providers, and biopharma companies, helping them navigate the complexities of the healthcare system. With a workforce of around 139 employees, the company has established itself as a trusted partner in the commercialization of rare disease therapies, boasting a portfolio that includes exclusive therapies and participation in limited distribution networks. Their commitment to patient care is evident in their proactive approach to managing treatment journeys, ensuring that patients receive the support they need throughout their therapy.

24. Tanner Pharma Group

• Website: tannerpharma.com
• Ownership type: Private
• Headquarters: Charlotte, North Carolina, United States (USA)
• Employee distribution: United States (USA) 55%, United Kingdom (UK) 37%, Switzerland 4%, Other 4%
• Founded year: 2002
• Headcount: 51-200
• LinkedIn: tanner-pharmaceuticals

Tanner Pharma Group, founded in 2002 and based in Charlotte, North Carolina, is a healthcare solutions provider that specializes in access solutions and clinical services. The company assists pharmaceutical companies and healthcare organizations in enhancing access to medicines, managing clinical trials, and navigating complex regulatory environments. With a workforce of approximately 104 employees, Tanner Pharma operates in various global markets, including the United States, the United Kingdom, and Switzerland. Their services include expanded access programs, compassionate use initiatives, and strategies to address drug shortages. Tanner Pharma is committed to improving health equity and has positively impacted thousands of lives by ensuring that essential medications reach those in need. Their involvement in international commercialization and clinical supply chain management further solidifies their position within the pharmaceutical industry.

25. Kriya Therapeutics, Inc.

• Website: kriyatx.com
• Ownership type: Private
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: kriyatherapeutics

Kriya Therapeutics, Inc. is a biotechnology firm based in Morrisville, North Carolina, founded in 2019. The company specializes in the development of gene therapies aimed at addressing various medical conditions, including diabetes, neurological disorders, and eye diseases. Kriya's mission is to make gene therapies accessible to a broader patient population, focusing on significant unmet medical needs. Their product pipeline includes several promising candidates, such as KRIYA-825 for Geographic Atrophy and KRIYA-839 for diabetes, which are designed to provide durable treatment solutions. Kriya operates through rigorous research and development efforts, with a team of experienced professionals in gene therapy and complex biologics. The company is committed to advancing its innovative therapies to improve patient outcomes and quality of life.

Pharmaceuticals Companies Insights: Key Companies in North Carolina

Want to Find More Pharmaceuticals Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!